Drug:
Reaction: MYELOSUPPRESSION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940213 |
CN |
50 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 2 | 26940613 |
CN |
68 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 3 | 26940626 |
CN |
39 | 2 |
Myelosuppression, |
||||
FRUQUINTINIB, |
||||
| 4 | 26940782 |
CN |
72 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, |
||||
| 5 | 26940969 |
CN |
74 | 2 |
Myelosuppression, Off label use, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, |
||||
| 6 | 26941187 |
CN |
45 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 7 | 26941219 |
CN |
52 | 1 |
Myelosuppression, Puncture site pain, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 8 | 26941231 |
CN |
47 | 1 |
Myelosuppression, White blood cell count decreased, |
||||
| 9 | 26941368 |
CN |
73 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, CAPECITABINE, CAPECITABINE, OXALIPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, WATER, ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO, |
||||
| 10 | 26941614 |
CN |
63 | 2 |
Myelosuppression, White blood cell count decreased, Granulocyte count decreased, |
||||
VENETOCLAX, |
||||
| 11 | 26941908 |
|||
Drug reaction with eosinophilia and systemic symptoms, Condition aggravated, Tubulointerstitial nephritis, Normochromic normocytic anaemia, Myelosuppression, |
||||
LINEZOLID, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 12 | 26941988 |
CN |
61 | 1 |
Myelosuppression, Infection, Pyrexia, |
||||
CARBOPLATIN, CARBOPLATIN, BORTEZOMIB, BORTEZOMIB, IFOSFAMIDE, IFOSFAMIDE, ETOPOSIDE, ETOPOSIDE, |
||||
| 13 | 26942068 |
CN |
67 | 2 |
White blood cell count decreased, Fatigue, Myelosuppression, Discomfort, Oropharyngeal pain, Malignant neoplasm progression, Platelet count decreased, Haemoglobin decreased, |
||||
VENETOCLAX, SELINEXOR, CYTARABINE, AZACITIDINE, AZACITIDINE FOR, |
||||
| 14 | 26942270 |
CN |
41 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 15 | 26942380 |
CN |
47 | 2 |
Myelosuppression, Bone marrow failure, Haemorrhage intracranial, Potentiating drug interaction, Treatment noncompliance, Off label use, |
||||
OLAPARIB, OLAPARIB, TEMOZOLOMIDE, TEMOZOLOMIDE, ATEZOLIZUMAB, ATEZOLIZUMAB, |
||||
| 16 | 26942521 |
JP |
9 | 1 |
Myelosuppression, |
||||
ATEZOLIZUMAB, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, |
||||
| 17 | 26942526 |
CN |
2 | |
Myelosuppression, |
||||
RITUXIMAB, RITUXIMAB, DEXAMETHASONE SODIUM PHOSPHATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 18 | 26942602 |
CN |
52 | 1 |
Myelosuppression, |
||||
OBINUTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 19 | 26942623 |
CN |
56 | 1 |
Myelosuppression, |
||||
LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 20 | 26942657 |
55 | 2 | |
Myelosuppression, Radiation pneumonitis, Diarrhoea, |
||||
ABEMACICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, BETAMETHASONE DIPROPIONATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 21 | 26942897 |
CN |
||
Decreased appetite, Gastrointestinal disorder, Myelosuppression, Hepatic function abnormal, Renal impairment, Proteinuria, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, |
||||
| 22 | 26942907 |
4 | 2 | |
Deep vein thrombosis, Myelosuppression, Pancreatic enzymes increased, Off label use, |
||||
ETOPOSIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, METHYLPREDNISOLONE, |
||||
| 23 | 26943317 |
JP |
57 | 2 |
Myelosuppression, Therapy partial responder, |
||||
PEMBROLIZUMAB, |
||||
| 24 | 26943489 |
CN |
35 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 25 | 26943494 |
CN |
59 | 2 |
Myelosuppression, Asthenia, |
||||
TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 26 | 26943504 |
CN |
63 | 1 |
Myelosuppression, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, |
||||
| 27 | 26943564 |
CN |
58 | 2 |
Myelosuppression, Full blood count decreased, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 28 | 26943991 |
CN |
75 | 2 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, |
||||
| 29 | 26944246 |
71 | 2 | |
Myelosuppression, Neutrophil count decreased, White blood cell count decreased, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 30 | 26944247 |
64 | 2 | |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 31 | 26944250 |
57 | 1 | |
Myelosuppression, Asthenia, Pyrexia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 32 | 26944251 |
42 | 2 | |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 33 | 26944381 |
CN |
69 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
TRASTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 34 | 26945518 |
CN |
70 | 2 |
Myelosuppression, |
||||
RIBOCICLIB, |
||||
| 35 | 26947115 |
CN |
63 | 1 |
Myelosuppression, Vomiting, Rash, Diarrhoea, Abdominal discomfort, Urticaria, Hypersensitivity, Product use issue, |
||||
IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, CYTARABINE, WATER, STERILE WATER, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 36 | 26947116 |
CN |
2 | |
Myelosuppression, Platelet count decreased, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 37 | 26947117 |
CN |
69 | 1 |
Myelosuppression, Agranulocytosis, White blood cell count decreased, Asthenia, Underdose, |
||||
IVOSIDENIB, |
||||
| 38 | 26947118 |
CN |
68 | 2 |
Myelosuppression, |
||||
IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, |
||||
| 39 | 26934123 |
CN |
74 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, |
||||
| 40 | 26934147 |
CN |
60 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 41 | 26934266 |
CN |
58 | 1 |
Myelosuppression, Granulocyte count decreased, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 42 | 26934272 |
CN |
71 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 43 | 26934376 |
CN |
74 | 2 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 44 | 26934402 |
CN |
57 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 45 | 26934404 |
CN |
78 | 1 |
Myelosuppression, |
||||
| 46 | 26934635 |
CN |
63 | 2 |
Myelosuppression, |
||||
OSIMERTINIB, |
||||
| 47 | 26934658 |
CN |
54 | 2 |
Myelosuppression, |
||||
ERIBULIN MESYLATE, |
||||
| 48 | 26934734 |
CN |
69 | 2 |
Myelosuppression, |
||||
DENOSUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 49 | 26934933 |
CN |
77 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 50 | 26934952 |
CN |
76 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED DISODIUM, BEVACIZUMAB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 51 | 26934971 |
CN |
70 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 52 | 26934972 |
CN |
61 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 53 | 26934977 |
CN |
82 | 2 |
Myelosuppression, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 54 | 26934992 |
CN |
56 | 1 |
Myelosuppression, Pyrexia, Diarrhoea, Abdominal pain, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 55 | 26935010 |
CN |
80 | 1 |
Myelosuppression, White blood cell count decreased, |
||||
OXALIPLATIN, OXALIPLATIN, |
||||
| 56 | 26935018 |
CN |
57 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 57 | 26935036 |
CN |
59 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 58 | 26935048 |
CN |
77 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 59 | 26935049 |
CN |
73 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, |
||||
| 60 | 26935051 |
CN |
69 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 61 | 26935078 |
CN |
67 | 1 |
Myelosuppression, |
||||
| 62 | 26935177 |
CN |
73 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED DISODIUM, |
||||
| 63 | 26935222 |
CN |
75 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 64 | 26935231 |
CN |
61 | 1 |
Myelosuppression, |
||||
CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 65 | 26935474 |
CN |
59 | 2 |
Myelosuppression, Chest discomfort, Dyspnoea, |
||||
INAVOLISIB, ABEMACICLIB, |
||||
| 66 | 26935534 |
JP |
8 | 1 |
Myelosuppression, |
||||
AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT), CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 67 | 26935541 |
CN |
63 | 2 |
White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Myelosuppression, |
||||
INAVOLISIB, PALBOCICLIB, |
||||
| 68 | 26935565 |
JP |
2 | |
Myelosuppression, Neutrophil count decreased, Platelet count decreased, |
||||
DURVALUMAB, CISPLATIN, GEMCITABINE HYDROCHLORIDE, |
||||
| 69 | 26935690 |
CN |
44 | 1 |
Myelosuppression, White blood cell count decreased, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 70 | 26935755 |
CN |
57 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, DEXRAZOXANE FOR INJECTION, DEXRAZOXANE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, |
||||
| 71 | 26935759 |
CN |
73 | 2 |
Myelosuppression, Febrile infection, Off label use, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, |
||||
| 72 | 26936392 |
4 | 2 | |
Herpes zoster, Myelosuppression, Off label use, |
||||
ETOPOSIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, METHYLPREDNISOLONE, |
||||
| 73 | 26936393 |
7 | 2 | |
Pancreatitis acute, Myelosuppression, Off label use, |
||||
ETOPOSIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, METHYLPREDNISOLONE, |
||||
| 74 | 26936464 |
US |
2 | |
Myelosuppression, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, REVUMENIB, |
||||
| 75 | 26936510 |
CN |
18 | 2 |
Myelosuppression, |
||||
BRENTUXIMAB VEDOTIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DACARBAZINE, |
||||
| 76 | 26936521 |
CN |
46 | 2 |
Myelosuppression, Pyrexia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 77 | 26936534 |
CN |
63 | 2 |
White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Myelosuppression, |
||||
PALBOCICLIB, INAVOLISIB, |
||||
| 78 | 26936550 |
CN |
69 | 2 |
Myelosuppression, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 79 | 26936607 |
CN |
63 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 80 | 26936625 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 81 | 26937277 |
CN |
72 | 1 |
Myelosuppression, Haemodynamic instability, Interleukin level increased, Diabetes insipidus, Systemic inflammatory response syndrome, Atrial fibrillation, Pyrexia, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 82 | 26937295 |
CN |
56 | 2 |
Myelosuppression, Neutrophil count decreased, Platelet count decreased, White blood cell count decreased, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 83 | 26937728 |
CN |
63 | 2 |
Muscular weakness, Dizziness, Myelosuppression, Musculoskeletal pain, |
||||
ABEMACICLIB, FULVESTRANT, |
||||
| 84 | 26937740 |
59 | 2 | |
Myelosuppression, |
||||
ABEMACICLIB, ABEMACICLIB, INAVOLISIB, INAVOLISIB, |
||||
| 85 | 26937745 |
JP |
65 | 1 |
Myelosuppression, |
||||
| 86 | 26938820 |
CN |
49 | 2 |
Myelosuppression, |
||||
CAPECITABINE, |
||||
| 87 | 26938821 |
CN |
62 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, |
||||
| 88 | 26932375 |
CN |
48 | 2 |
Myelosuppression, Granulocytopenia, Necrotising fasciitis, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, LENALIDOMIDE, |
||||
| 89 | 26933389 |
CN |
55 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 90 | 26933906 |
CN |
72 | 1 |
Myelosuppression, |
||||
| 91 | 26926677 |
CN |
74 | 2 |
Myelosuppression, |
||||
OLAPARIB, |
||||
| 92 | 26926846 |
CN |
44 | 1 |
Salmonellosis, Myelosuppression, Candida infection, |
||||
DECITABINE, CYTARABINE, |
||||
| 93 | 26927243 |
CN |
46 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, |
||||
| 94 | 26927369 |
CN |
74 | 1 |
Myelosuppression, Asthenia, Oedema, |
||||
| 95 | 26927733 |
CN |
58 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, CARBOPLATIN, |
||||
| 96 | 26927855 |
CN |
71 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 97 | 26928511 |
CN |
51 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, |
||||
| 98 | 26929139 |
CN |
62 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 99 | 26930456 |
JP |
2 | |
Myelodysplastic syndrome, Second primary malignancy, Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 100 | 26930827 |
CN |
2 | |
Myelosuppression, Treatment noncompliance, Bone marrow failure, Haemorrhage intracranial, Potentiating drug interaction, Off label use, |
||||
TEMOZOLOMIDE, TEMOZOLOMIDE, ATEZOLIZUMAB, ATEZOLIZUMAB, OLAPARIB, OLAPARIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30